Astronics (ATRO) Q4 2003 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2003 earnings summary
5 Nov, 2026Executive summary
2003 remained profitable despite lower aircraft demand and the completion of the F-16 night-vision retrofit program; core sales excluding F-16 were relatively flat.
Strategy centered on expanding from lighting components to integrated aircraft lighting systems, increasing technical capability and revenue content per aircraft.
Financial highlights
Net sales were $33.2 million, down 22.6% YoY; excluding F-16 sales, revenue was $32.5 million versus $32.8 million in 2002.
Income from continuing operations was $782,000 versus $4.047 million; net income was $1.113 million versus $4.553 million.
Diluted EPS from continuing operations was $0.10 versus $0.49; diluted net EPS was $0.14 versus $0.55.
Cost of sales rose to 79.7% of revenue from 71.5%; R&D expense increased to $3.6 million from $2.7 million.
Outlook and guidance
2004 results were expected to resemble 2003, with a potentially slightly higher top line offset by increased development spending.
2004 priorities included technology development and qualification for contracts won in 2002–03, with added technical staff and R&D spending at or slightly above 2003 levels.
Production from many awarded programs was not expected to materially affect revenue until 2005 and beyond; 2005 was forecast to deliver double-digit growth.
Latest events from Astronics
- Record Q3 results and backlog support 2027 growth despite supply and timing risks.ATRO
Q3 2026 - Record earnings and a $40.198M backlog supported a strong 2000 shipment outlook.ATRO
Q4 1999 - Record growth led by F-16 demand; 2001 sales target exceeded $85M.ATRO
Q4 2000 - Record 2001 results met weakening demand as F-16 production neared its end.ATRO
Q4 2001 - F-16 sales faded, but stable margins and the JSF award shaped the next growth phase.ATRO
Q4 2002 - Higher development spending drove a 2004 loss as backlog and AES set up 2005 growth.ATRO
Q4 2004 - FY05 sales surged 117%; $95.1M backlog supports growth, tempered by certification risks.ATRO
Q4 2005 - Strong FY06 growth and FY07 outlook, tempered by restatements and control weaknesses.ATRO
Q4 2006 - Sales grew, but Eclipse charges cut FY08 earnings as DME reshaped the FY09 outlook.ATRO
Q4 2008